SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-001725
Filing Date
2023-02-14
Accepted
2023-02-14 16:16:36
Documents
55
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cvm_10q.htm   iXBRL 10-Q 575451
2 CERTIFICATION cvm_ex31.htm EX-31 25736
3 CERTIFICATION cvm_ex32.htm EX-32 4378
  Complete submission text file 0001654954-23-001725.txt   3363358

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cvm-20221231.xsd EX-101.SCH 42836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20221231_lab.xml EX-101.LAB 241238
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20221231_cal.xml EX-101.CAL 39459
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20221231_pre.xml EX-101.PRE 193464
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20221231_def.xml EX-101.DEF 86150
49 EXTRACTED XBRL INSTANCE DOCUMENT cvm_10q_htm.xml XML 465101
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 23629567
SIC: 2836 Biological Products, (No Diagnostic Substances)